ArticleInternational journal of environmental research and public health2026
From Invisibility to Inclusion: Evidence, Lived Experience, and Policy Directions for Multiple Chemical Sensitivity Report from the Resilience 2025 International Conference.
Article in International journal of environmental research and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Organized by the Environmental Health Association of Canada (EHAC-ASEC) and the Environmental Health Association of Quebec (ASEQ-EHAQ), Resilience: An International Conference on Multiple Chemical Sensitivity, a groundbreaking event, was held online over two days, on 1 and 2 May 2025, and brought together experts and stakeholders from multiple sectors to address a condition that has received limited attention in health, policy and research contexts. The conference convened leading international researchers, legal experts, medical professionals, policymakers, and advocates to examine one of the most pressing but under-represented public health and human rights challenges of our time. Multiple Chemical Sensitivity (MCS) is a disabling condition affecting a growing number of individuals globally. Despite its prevalence, MCS remains marginalized and under-recognized in healthcare systems, policy frameworks, and scientific discourse. The conference spanned 2 days, drew nearly 900 participants, and featured engaging presentations and discussions that integrated scientific evidence, lived experience, and cross-sector perspectives. A central theme emerged: recognition of MCS extends beyond medical considerations, encompassing accessibility, gender equity, environmental justice and human rights.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.